Kết quả tìm kiếm - Devinder Gill

  • Đang hiển thị 1 - 15 kết quả của 15
Tinh chỉnh kết quả
  1. 1
    Incidence and nature of CD20‐negative relapses following rituximab therapy in aggressive B‐cell non‐Hodgkin's lymphoma: a retrospective review

    Incidence and nature of CD20‐negative relapses following rituximab therapy in aggressive B‐cell non‐Hodgkin's lymphoma: a retrospective review Bằng Glen Kennedy, Siok‐Keen Tey, Ralph Cobcroft, Paula Marlton, Gavin Cull, Karen Grimmett, Damien Thomson, Devinder Gill

    Được phát hành 2002
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells<i>in vitro</i>

    CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells<i>in vitro</i> Bằng Melinda Burgess, Catherine Cheung, Lynne Chambers, Karunya Jenin Ravindranath, Gunjeet Minhas, Louise Knop, Peter Mollee, Nigel A.J. McMillan, Devinder Gill

    Được phát hành 2012
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients

    Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients Bằng Maher K. Gandhi, Eleanore Lambley, Jaikumar Duraiswamy, Ujjwal Dua, Corey Smith, Suzanne Elliott, Devinder Gill, Paula Marlton, John F. Seymour, Rajiv Khanna

    Được phát hành 2006
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphoma

    Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphoma Bằng Maher K. Gandhi, Guido Moll, Corey Smith, Ujjwal Dua, Eleanore Lambley, Olivier Ramuz, Devinder Gill, Paula Marlton, John F. Seymour, Rajiv Khanna

    Được phát hành 2007
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

    Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study Bằng Michael A. Rieger, Anders Österborg, Ruth Pettengell, Darrell White, Devinder Gill, Jan Walewski, Evelyn Kuhnt, Markus Loeffler, Michael Pfreundschuh, Anthony D. Ho

    Được phát hành 2010
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma

    Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma Bằng Kimberley Jones, Frank Vari, Colm Keane, Pauline Crooks, Jamie P. Nourse, Louise Seymour, David Gottlieb, David Ritchie, Devinder Gill, Maher K. Gandhi

    Được phát hành 2012
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure

    Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedu... Bằng Andrew Spencer, H. Miles Prince, Andrew W. Roberts, I Prosser, Kenneth F. Bradstock, Luke Coyle, Devinder Gill, Noemi Horvath, John Reynolds, Nola Kennedy

    Được phát hành 2009
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

    Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era Bằng Christian Gisselbrecht, Bertram Glaß, Nicolas Mounier, Devinder Gill, David C. Linch, Marek Trněný, André Bosly, Nicolas Ketterer, Ofer Shpilberg, Hans Hagberg, Dávid Ma, Josette Brière, Craig H. Moskowitz, Norbert Schmitz

    Được phát hành 2010
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Diagnosis of fusion genes using targeted RNA sequencing

    Diagnosis of fusion genes using targeted RNA sequencing Bằng Erin E. Heyer, Ira W. Deveson, Danson Wooi, Christina Selinger, Ruth J. Lyons, Vanessa M. Hayes, Sandra O’Toole, Mandy L. Ballinger, Devinder Gill, David M. Thomas, Tim R. Mercer, James Blackburn

    Được phát hành 2019
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab &lt;i&gt;versus&lt;/i&gt; chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

    First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab &lt;i&gt;versus&lt;/i&gt; chlorambucil plus obinutuzumab: final analysis of the randomized, ph... Bằng Carol Moreno, Richard Greil, Fatih Demırkan, Alessandra Tedeschi, Bertrand Anz, Loree Larratt, Martin Šimkovič, Jan Novák, Владимир Стругов, Devinder Gill, John G. Gribben, Kevin Kwei, Sandra Dai, Emily Hsu, James P. Dean, Ian W. Flinn

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

    Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study Bằng Marco Montillo, Susan O’Brien, Alessandra Tedeschi, John C. Byrd, Claire Dearden, Devinder Gill, Jennifer R. Brown, Jacqueline C. Barrientos, Stephen P. Mulligan, Richard R. Furman, Florence Cymbalista, Clara Plascencia, S. Chang, Emily Hsu, Danelle F. James, Peter Hillmen

    Được phát hành 2017
    lấy văn bản
    Carta
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

    Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study Bằng Éric Van Den Neste, Norbert Schmitz, Nicolas Mounier, Devinder Gill, David C. Linch, Marek Trněný, R Bouadballah, John Radford, Mario Bargetzi, Vincent Ribrag, Ulrich Dührsen, Dávid Ma, Josette Brière, Catherine Thiéblemont, Emmanuel Bachy, Craig H. Moskowitz, B. Glaß, C Gisselbrecht

    Được phát hành 2016
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20<sup>+</sup> Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

    Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20<sup>+</sup> Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborati... Bằng Christian Gisselbrecht, Norbert Schmitz, Nicolas Mounier, Devinder Gill, David C. Linch, Marek Trněný, André Bosly, Nöel Milpied, John Radford, Nicolas Ketterer, Ofer Shpilberg, Ulrich Dührsen, Hans Hagberg, Daniel David, Andreas Viardot, Ray M. Lowenthal, Josette Brière, Gilles Salles, Craig H. Moskowitz, Bertram Glaß

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  14. 14
    Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

    Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients a... Bằng Mark Hertzberg, Maher K. Gandhi, Judith Trotman, Belinda Butcher, John Taper, Amanda Johnston, Devinder Gill, Shir‐Jing Ho, Gavin Cull, Keith Fay, Geoff Chong, Andrew Grigg, Ian D. Lewis, Sam Milliken, William Renwick, Uwe Hahn, Robin Filshie, George Kannourakis, Anne-Marie Watson, Pauline Warburton, Andrew Wirth, John F. Seymour, Michael S. Hofman, Rodney J. Hicks

    Được phát hành 2016
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  15. 15
    Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

    Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia Bằng John C. Byrd, Jennifer R. Brown, Susan O’Brien, Jacqueline C. Barrientos, Neil E. Kay, Nishitha Reddy, Steven Coutré, Constantine S. Tam, Stephen P. Mulligan, Ulrich Jaeger, Stephen Devereux, Paul M. Barr, Richard R. Furman, Thomas J. Kipps, Florence Cymbalista, Christopher Pocock, Patrick Thornton, Federico Caligaris‐Cappio, Tadeusz Robak, Julio Delgado, Stephen J. Schuster, Marco Montillo, Anna Schuh, Sven de Vos, Devinder Gill, Adrian Bloor, Claire Dearden, Carol Moreno, Jeffrey J. Jones, Alvina D. Chu, Maria Fardis, Jesse McGreivy, Fong Clow, Danelle F. James, Peter Hillmen

    Được phát hành 2014
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: